SEC 13F Intelligence

First National Bank Of Omaha / ABT

First National Bank Of Omaha’s Abbott Laboratories Position

Does First National Bank Of Omaha own Abbott Laboratories (ABT)? Yes — 172.8K shares worth $18M (+0.55% of its 13F portfolio) as of Q1 2026, up from 170.8K shares the prior filed quarter.

Position Value
$18M
Q1 2026
Shares
172.8K
% of Portfolio
+0.55%
Quarters Held
28
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $9MQ3 ’19: $8MQ4 ’19: $9MQ4 ’19Q1 ’20: $8MQ2 ’20: $9MQ3 ’20: $10MQ4 ’20: $11MQ4 ’20Q1 ’21: $16MQ2 ’21: $16MQ3 ’21: $19MQ4 ’21: $22MQ4 ’21Q1 ’22: $18MQ3 ’22: $15MQ4 ’22: $15,822Q1 ’23: $20MQ1 ’23Q2 ’23: $24MQ3 ’23: $20MQ4 ’23: $22MQ1 ’24: $22MQ1 ’24Q2 ’24: $20MQ3 ’24: $22MQ4 ’24: $21MQ2 ’25: $22MQ2 ’25Q3 ’25: $20MQ4 ’25: $21MQ1 ’26: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026172.8K$18M+0.55%
Q4 2025170.8K$21M+0.63%
Q3 2025148.2K$20M+1.25%
Q2 2025167.0K$22M+1.51%
Q4 2024189.6K$21M+1.39%
Q3 2024193.9K$22M+1.41%
Q2 2024188.2K$20M+1.29%
Q1 2024190.3K$22M+1.34%
Q4 2023201.2K$22M+1.40%
Q3 2023206.7K$20M+1.30%
Q2 2023221.6K$24M+1.39%
Q1 2023200.2K$20M+1.23%
Q4 2022144.1K$15,822+0.98%
Q3 2022153.2K$15M+0.97%
Q1 2022153.2K$18M+0.93%
Q4 2021157.4K$22M+1.06%
Q3 2021162.8K$19M+0.98%
Q2 2021132.5K$16M+0.83%
Q1 2021132.5K$16M+0.83%
Q4 202095.9K$11M+0.57%
Q3 202095.5K$10M+0.65%
Q2 202095.5K$9M+0.58%
Q1 202096.1K$8M+0.59%
Q4 201998.2K$9M+0.52%
Q3 2019100.6K$8M+0.54%
Q2 2019102.9K$9M+0.56%
Q1 2019104.5K$8M+0.57%
Q4 2018102.1K$7M+0.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First National Bank Of Omaha’s full portfolio or all institutional holders of ABT.